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Chronic Severe Mitral RegurgitationWe read with interest the letter by Drs. Raﬁque and
Siegel, and thank them for their comments. In our
subpopulation of surgical patients, they show if one
uses the additional criterion of a left ventricular end-
diastolic dimension (LVEDD) $55 mm, concordance
between echocardiography and magnetic resonance
imaging (MRI) improves from 32% to 58%. They
conclude LVEDD should be a key parameter in the
echocardiographic assessment of chronic mitral
regurgitation (MR).
It is well accepted that chronic MR causes an in-
crease in LV size. We previously used this important
relationship to validate the accuracy of MRI for quan-
tifying regurgitant volume (1). We showed a tight
coupling between MR regurgitant volume and LV end-
diastolic volume (r2 ¼ 0.8), but this study was limited
to patients with isolated, primary MR.
Using LV size as an additional criterion may
improve the accuracy of echocardiography in a pop-
ulation of patients, but it is no substitute for the ac-
curate determination of MR severity in an individual
patient. This is because many other common diseases
and conditions affect LV size. Myocardial infarction,
nonischemic cardiomyopathy, and athletic heart can
substantially increase LV size without increasing MR.
Similarly, diseases such as restrictive cardiomyopa-
thy and aortic stenosis can substantially decrease LV
size without decreasing MR. Table 4 shows the limi-
tations of using LVEDD as a criterion for MR severity
(2). For example, patient #29 had an LVEDD of 62 mm,
yet had mild MR, and patient #38 had an LVEDD of
53 mm, yet had severe MR.
Using LV size as a surrogate to avoid overestimation
of MR severity is similar to the strategy advocated by
some, to delay surgery until patients are symptomatic.
The thought being that the presence of symptoms
avoids the possibility of inappropriate surgery in MR
patients that are mistakenly graded as severe (3).
However, as is the case with using any surrogate, a
potential problem is the possibility of confounding
illnesses, especially when they are common. Consider2 relatively common conditions: mild MR and restric-
tive cardiomyopathy. A patient with symptomatic
restrictive cardiomyopathy and mild MR that is
mistakenly graded as severe by echocardiography is at
high risk of undergoing inappropriate surgery.
In summary, we believe echocardiographers should
use all information available to them, including LV
size, to determine MR severity. However, given the
potential inaccuracy of echocardiography, and the cost
and complications of open heart surgery, we are
steadfast in our conclusion that cardiac MRI should be
a strong consideration when important clinical de-
cisions are being made based on MR severity, even in
the presence of symptoms.Seth Uretsky, MD
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Aortic StiffnessComplex Evaluation But Major
Prognostic Signiﬁcance Before TAVRWe read with great interest the paper by Yotti et al.
(1) regarding vascular load and transcatheter aortic
valve replacement (TAVR). This study underlines the
interaction between valvular and vascular functions
in patients with aortic stenosis (AS). The authors
highlighted the increase of vascular load after TAVR,
which limits the afterload relief acutely and may
endanger the cardiovascular prognosis later on.
Although no outcome data were available in this
study, we recently conﬁrmed this prognostic impact
by assessing the signiﬁcance of ascending aortic cal-
ciﬁcations (AAC)—a surrogate of stiffness measured
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after TAVR (2). An impaired survival was clearly evi-
denced in patients with a calciﬁed aorta indepen-
dently of usual confounders.
The study by Yotti et al. (1) also suggests that the
usual tools would be unable to assess vascular
impedance while the aorta is unloaded because of AS.
It is rather challenging to separate valvular and
vascular functions (3) and evidently, although very
accurate, the approach used by Yotti et al. (1) could
not be used routinely. Quantifying AAC on the sys-
tematic pre-TAVR computed tomography is an easy
way to estimate aortic stiffness that should be more
appropriate in the presence of AS because it is pres-
sure independent.
We would like to emphasize the critical role of
vascular load after TAVR while it is currently
neglected. This deserves, to our view, implementing
a simple stiffness index (e.g., AAC), in the pre-TAVR
work-up. On top of being a stratifying variable that
should be considered to reﬁne the medical decision,
high vascular load represents a potential avenue for
new destiffening strategies and prompts us to target
high blood pressure.*Brahim Harbaoui, MD
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288:H1874–84.REPLY: Aortic StiffnessComplex Evaluation But Major Prognostic Signiﬁcance
Before TAVRWe very much appreciate the interest of Dr. Harbaoui
and colleagues in our work (1). Their letter furtherelaborates on the clinical relevance that systemic
vascular load may have in patients with aortic ste-
nosis (AS) undergoing valve replacement. In this re-
gard, we would like to emphasize that our study was
designed to address speciﬁcally the impact of the
stenotic valve on measurements of vascular load. For
this purpose, we combined state-of-the-art mea-
surement and signal-processing techniques with the
mechanistic model of acute relief of the valvular load
provided by transcatheter aortic valve replacement
(TAVR). Albeit limited to a small sample size, we
provided ancillary follow-up data suggesting a po-
tential link between the acute vascular changes
and the clinical functional improvement after the
intervention (2). This should be interpreted only as
a hypothesis-driven ﬁnding, which must be con-
ﬁrmed in a large clinical cohort. However, the highly
sophisticated methods we used in our study are
obviously nonsuitable for this purpose.
Systemic arterial compliance can be accurately
approximated noninvasively using echocardiography
and sphygmomanometry in patients without AS (3),
and has proved to be a very powerful predictor of
cardiovascular events in a number of populations.
Data from our study (2) validates the noninvasive
surrogate of systemic arterial compliance in patients
with AS (intraclass correlation coefﬁcient ¼ 0.82 and
0.80 vs. the gold-standard invasive exponential
decay and the diastolic area methods, respectively;
n ¼ 46 pooled pre- and post-TAVR data). Alternative
indices based on tonometry (4) and ultrasound-
based wave-intensity analyses (5) are also proven
predictors of cardiovascular events, but have not
been validated in the presence of AS. Quantifying the
degree of ascending aortic calciﬁcation as proposed
by Harbaoui et al. is an interesting surrogate of
arterial stiffness because it is particularly well suited
to ﬁt in the screening workﬂow of patients consid-
ered for valve replacement, but more evidence sup-
porting its clinical value is needed.
We believe the results of our ﬁndings suggest
that metrics of vascular load should be incorporated
to optimize patient periprocedural management.
Long-term prospective studies will ﬁnally establish
the prognostic value of measuring the ventricular-
vascular interaction before and after valve in-
terventions. Particularly important is to clarify the
confusion caused by diastolic dysfunction, kidney
disease, age, and coronary artery disease, amongst
other highly prevalent conditions in patients with AS.
Only when such information becomes available it shall
be possible to establish how indices of vascular load
may aid selecting the best management strategy for
patients with AS.
